DrugPatentWatch Database Preview
Profile for Canada Patent: 2147044
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
US Patent Family Members and Approved Drugs for Canada Patent: 2147044
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | Jan 21, 2019 | Noden Pharma | TEKTURNA | aliskiren hemifumarate |
Start Trial | Jan 21, 2019 | Noden Pharma | TEKTURNA HCT | aliskiren hemifumarate; hydrochlorothiazide |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |